RIGL
Rigel Pharmaceuticals Inc
46.60$
+1.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -1,354.8% | – | – | +140.4% | |
| – | -39.0% | -34.6% | -50.6% | +27.7% | +15.0% | +3.4% | +64.6% | -14.1% | +24.0% | +80.0% | +8.4% | |
| – | -24.4% | -0.9% | -18.4% | +28.7% | +18.3% | -19.9% | +30.0% | +30.6% | -28.9% | +40.7% | +2.6% | |
| – | -24.2% | +9.8% | -34.8% | +46.6% | +18.3% | -19.9% | +76.9% | +1.2% | – | – | – | |
| – | – | -182.0% | – | – | +304.1% | -282.0% | – | -398.9% | – | -98.4% | -12,852.9% | |
| – | +32.2% | +47.3% | -79.6% | +574.4% | +31.6% | -13.3% | -50.3% | -28.2% | +3,233.3% | -97.4% | -100.0% | |
| – | -29.1% | -44.2% | -178.3% | – | -194.8% | – | -268.6% | – | -105.9% | – | -2,336.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +502.8% | +257.1% | +367.3% | -38.9% | -97.8% | +64.7% | +83.9% | -55.5% | -100.0% | – | -100.0% | |
| – | – | – | +0.0% | +0.0% | +0.0% | +1.9% | +95.9% | +0.0% | +2.1% | -100.0% | – | |
| – | +502.8% | +257.1% | +367.3% | -38.9% | -84.2% | +10.6% | +398.6% | -89.5% | +180.4% | -163.4% | – | |
| – | – | -191.4% | – | +84.1% | -241.5% | – | -246.2% | – | +49.5% | +187.7% | -167.2% | |
| – | – | – | – | – | – | – | – | -1,513.2% | – | – | +143.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.